| Year |
Citation |
Score |
| 2024 |
Richardson TE, Walker JM, Hambardzumyan D, Brem S, Hatanpaa KJ, Viapiano MS, Pai B, Umphlett M, Becher OJ, Snuderl M, McBrayer SK, Abdullah KG, Tsankova NM. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma. Acta Neuropathologica. 148: 5. PMID 39012509 DOI: 10.1007/s00401-024-02761-7 |
0.387 |
|
| 2024 |
Read RD, Tapp ZM, Rajappa P, Hambardzumyan D. Glioblastoma microenvironment-from biology to therapy. Genes & Development. PMID 38811170 DOI: 10.1101/gad.351427.123 |
0.433 |
|
| 2023 |
Ross JL, Hambardzumyan D. Et tu neutrophils? The brain reprograms neutrophils to facilitate tumor progression. Immunity. 56: 2469-2471. PMID 37967529 DOI: 10.1016/j.immuni.2023.10.006 |
0.639 |
|
| 2023 |
Chen Z, Giotti B, Kaluzova M, Puigdelloses Vallcorba M, Rawat K, Price G, Herting CJ, Piñero G, Cristea S, Ross JL, Ackley J, Maximov V, Szulzewsky F, Thomason W, Marquez-Ropero M, ... ... Hambardzumyan D, et al. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. The Journal of Clinical Investigation. PMID 37733448 DOI: 10.1172/JCI163802 |
0.672 |
|
| 2023 |
Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, Oh YT, Kim HJ, Jung CW, Pinero G, Joshi T, Hambardzumyan D, Sakaguchi T, Hubert CG, McIntyre TM, et al. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. Cancer Cell. PMID 37451272 DOI: 10.1016/j.ccell.2023.06.007 |
0.309 |
|
| 2023 |
Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, Ramakrishnan A, Shen L, Tsankov AM, Hambardzumyan D, Friedel RH, Zou H. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. PMID 37451265 DOI: 10.1016/j.immuni.2023.06.017 |
0.59 |
|
| 2023 |
McSwain LF, Pillsbury CE, Haji-Seyed-Javadi R, Rath SK, Chen V, Huang T, Shahab SW, Kunhiraman H, Ross J, Price GA, Dey A, Hambardzumyan D, MacDonald T, Yu DS, Porter CC, et al. Author Correction: YB1 modulates the DNA damage response in medulloblastoma. Scientific Reports. 13: 9717. PMID 37322047 DOI: 10.1038/s41598-023-36594-3 |
0.478 |
|
| 2023 |
McSwain LF, Pillsbury CE, Haji-Seyed-Javadi R, Rath SK, Chen V, Huang T, Shahab SW, Kunhiraman H, Ross J, Price GA, Dey A, Hambardzumyan D, MacDonald T, Yu DS, Porter CC, et al. YB1 modulates the DNA damage response in medulloblastoma. Scientific Reports. 13: 8087. PMID 37208357 DOI: 10.1038/s41598-023-35220-6 |
0.576 |
|
| 2023 |
Chen Z, Soni N, Pinero G, Giotti B, Eddins DJ, Lindblad KE, Ross JL, Puigdelloses Vallcorba M, Joshi T, Angione A, Thomason W, Keane A, Tsankova NM, Gutmann DH, Lira SA, ... ... Hambardzumyan D, et al. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nature Communications. 14: 1839. PMID 37012245 DOI: 10.1038/s41467-023-37361-8 |
0.727 |
|
| 2023 |
Friedmann-Morvinski D, Hambardzumyan D. Monocyte-neutrophil entanglement in glioblastoma. The Journal of Clinical Investigation. 133. PMID 36594465 DOI: 10.1172/JCI163451 |
0.473 |
|
| 2022 |
Bae E, Huang P, Müller-Greven G, Hambardzumyan D, Sloan AE, Nowacki AS, Marko N, Carlin CR, Gladson CL. Integrin α3β1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis. Nature Communications. 13: 4268. PMID 35879332 DOI: 10.1038/s41467-022-31981-2 |
0.379 |
|
| 2022 |
Tomita Y, Shimazu Y, Somasundaram A, Tanaka Y, Takata N, Ishi Y, Gadd S, Hashizume R, Angione A, Pinero G, Hambardzumyan D, Brat DJ, Hoeman CM, Becher OJ. A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M. Glia. PMID 35524725 DOI: 10.1002/glia.24189 |
0.329 |
|
| 2021 |
Puigdelloses M, Garcia-Moure M, Labiano S, Laspidea V, Gonzalez-Huarriz M, Zalacain M, Marrodan L, Martinez-Velez N, De la Nava D, Ausejo I, Hervás-Stubbs S, Herrador G, Chen Z, Hambardzumyan D, Patino Garcia A, et al. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models. Journal For Immunotherapy of Cancer. 9. PMID 34281988 DOI: 10.1136/jitc-2021-002644 |
0.566 |
|
| 2021 |
Price G, Bouras A, Hambardzumyan D, Hadjipanayis CG. Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma. Ebiomedicine. 69: 103453. PMID 34157482 DOI: 10.1016/j.ebiom.2021.103453 |
0.422 |
|
| 2021 |
Chen Z, Hambardzumyan D. Macrophage-tumor cell intertwine drives the transition into a mesenchymal-like cellular state of glioblastoma. Cancer Cell. PMID 34087163 DOI: 10.1016/j.ccell.2021.05.003 |
0.521 |
|
| 2021 |
Ross JL, Vega JV, Plant A, MacDonald TJ, Becher OJ, Hambardzumyan D. Tumor immune landscape of paediatric high-grade gliomas. Brain : a Journal of Neurology. PMID 33856022 DOI: 10.1093/brain/awab155 |
0.691 |
|
| 2021 |
Buonfiglioli A, Hambardzumyan D. Macrophages and microglia: the cerberus of glioblastoma. Acta Neuropathologica Communications. 9: 54. PMID 33766119 DOI: 10.1186/s40478-021-01156-z |
0.514 |
|
| 2020 |
Ross JL, Chen Z, Herting CJ, Grabovska Y, Szulzewsky F, Puigdelloses M, Monterroza L, Switchenko J, Wadhwani NR, Cimino PJ, Mackay A, Jones C, Read RD, MacDonald TJ, Schniederjan M, ... ... Hambardzumyan D, et al. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Brain : a Journal of Neurology. PMID 33300045 DOI: 10.1093/brain/awaa382 |
0.672 |
|
| 2020 |
De Boeck A, Ahn BY, D'Mello C, Lun X, Menon SV, Alshehri MM, Szulzewsky F, Shen Y, Khan L, Dang NH, Reichardt E, Goring KA, King J, Grisdale CJ, Grinshtein N, ... Hambardzumyan D, et al. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nature Communications. 11: 4997. PMID 33020472 DOI: 10.1038/s41467-020-18569-4 |
0.354 |
|
| 2020 |
Chen Z, Herting CJ, Ross JL, Gabanic B, Puigdelloses Vallcorba M, Szulzewsky F, Wojciechowicz ML, Cimino PJ, Ezhilarasan R, Sulman EP, Ying M, Ma'ayan A, Read RD, Hambardzumyan D. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia. PMID 32639068 DOI: 10.1002/Glia.23883 |
0.713 |
|
| 2020 |
Alexander J, LaPlant QC, Pattwell SS, Szulzewsky F, Cimino PJ, Caruso FP, Pugliese P, Chen Z, Chardon F, Hill AJ, Spurrell C, Ahrendsen D, Pietras A, Starita LM, Hambardzumyan D, et al. Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma. Glia. PMID 32621641 DOI: 10.1002/Glia.23866 |
0.575 |
|
| 2020 |
Haage V, Semtner M, Vidal RO, Hernandez DP, Pong WW, Chen Z, Hambardzumyan D, Magrini V, Ly A, Walker J, Mardis E, Mertins P, Sauer S, Kettenmann H, Gutmann DH. Correction to: Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathologica Communications. 8: 1. PMID 31915069 DOI: 10.1186/S40478-019-0875-3 |
0.46 |
|
| 2019 |
Herting CJ, Chen Z, Maximov V, Duffy A, Szulzewsky F, Shayakhmetov DM, Hambardzumyan D. Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. Brain : a Journal of Neurology. PMID 31665239 DOI: 10.1093/Brain/Awz331 |
0.569 |
|
| 2019 |
Kaffes I, Szulzewsky F, Chen Z, Herting CJ, Gabanic B, Velázquez Vega JE, Shelton J, Switchenko JM, Ross JL, McSwain LF, Huse JT, Westermark B, Nelander S, Forsberg-Nilsson K, Uhrbom L, ... ... Hambardzumyan D, et al. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors. Oncoimmunology. 8: e1655360. PMID 31646100 DOI: 10.1080/2162402X.2019.1655360 |
0.757 |
|
| 2019 |
Chen Z, Ross JL, Hambardzumyan D. Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages. Proceedings of the National Academy of Sciences of the United States of America. PMID 31235603 DOI: 10.1073/Pnas.1902366116 |
0.736 |
|
| 2019 |
Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, Hambardzumyan D, Kenney AM. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nature Communications. 10: 2410. PMID 31160587 DOI: 10.1038/S41467-019-10458-9 |
0.533 |
|
| 2019 |
Haage V, Semtner M, Vidal RO, Hernandez DP, Pong WW, Chen Z, Hambardzumyan D, Magrini V, Ly A, Walker J, Mardis E, Mertins P, Sauer S, Kettenmann H, Gutmann DH. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathologica Communications. 7: 20. PMID 30764877 DOI: 10.1186/S40478-019-0665-Y |
0.549 |
|
| 2019 |
Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, ... ... Hambardzumyan D, et al. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Science Translational Medicine. 11. PMID 30760578 DOI: 10.1126/Scitranslmed.Aaq1427 |
0.652 |
|
| 2019 |
Mastrella G, Hou M, Li M, Stoecklein VM, Zdouc N, Volmar MNM, Miletic H, Reinhard S, Herold-Mende CC, Kleber S, Eisenhut K, Gargiulo G, Synowitz M, Vescovi AL, Harter PN, ... ... Hambardzumyan D, et al. Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma. Cancer Research. PMID 30718358 DOI: 10.1158/0008-5472.Can-18-0881 |
0.456 |
|
| 2019 |
Boyd NH, Walker K, Ayokanmbi A, Gordon ER, Whetsel J, Smith CM, Sanchez RG, Lubin F, Chakraborty A, Tran AN, Herting C, Hambardzumyan D, Yancey Gillespie G, Hackney JR, Cooper SJ, et al. CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Glioblastoma Angiogenesis. Stem Cells (Dayton, Ohio). PMID 30629778 DOI: 10.1002/Stem.2969 |
0.487 |
|
| 2019 |
Chen Z, Hurting CJ, Gabanic B, Murukuti J, Hambardzumyan D. Abstract 1100: Genetic driver-mutations define composition and properties of tumor-associated myeloid cells in glioblastoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1100 |
0.6 |
|
| 2019 |
Ross J, Chen Z, Herting C, Szulzewsky F, Becher O, MacDonald T, Schniederjan M, Hambardzumyan D. PDTM-11. GAINING INSIGHTS INTO THE INFLAMMATORY MICROENVIRONMENT OF PEDIATRIC HIGH-GRADE GLIOMAS USING GEMMs AND PATIENT SAMPLES Neuro-Oncology. 21: vi189-vi189. DOI: 10.1093/Neuonc/Noz175.787 |
0.765 |
|
| 2019 |
Kälin R, Mastrella G, Hou M, Li M, Stoecklein V, Zdouc N, Volmar M, Miletic H, Reinhard S, Herold-Mende C, Kleber S, Eisenhut K, Gargiulo G, Synowitz M, Vescovi A, ... ... Hambardzumyan D, et al. ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA Neuro-Oncology. 21: vi30-vi30. DOI: 10.1093/Neuonc/Noz175.114 |
0.474 |
|
| 2019 |
Ross J, Chen Z, Szulzewsky F, Monterroza L, Schniederjan M, Becher O, Hambardzumyan D. TMOD-09. TUMOR ASSOCIATED MACROPHAGE DYNAMICS IN PEDIATRIC HIGH-GRADE GLIOMAS Neuro-Oncology. 21: ii123-ii123. DOI: 10.1093/Neuonc/Noz036.247 |
0.727 |
|
| 2018 |
Zheng H, Yu WM, Shen J, Kang S, Hambardzumyan D, Li JY, Shen Y, Kenney AM, Chen J, Qu CK. Mitochondrial oxidation of the carbohydrate fuel is required for neural precursor/stem cell function and postnatal cerebellar development. Science Advances. 4: eaat2681. PMID 30338292 DOI: 10.1126/Sciadv.Aat2681 |
0.309 |
|
| 2018 |
Chen Z, Hambardzumyan D. Immune Microenvironment in Glioblastoma Subtypes. Frontiers in Immunology. 9: 1004. PMID 29867979 DOI: 10.3389/Fimmu.2018.01004 |
0.667 |
|
| 2018 |
Sadahiro H, Kang KD, Gibson JT, Minata M, Yu H, Shi J, Chhipa RR, Chen Z, Lu S, Simoni Y, Furuta T, Sabit H, Zhang S, Bastola S, Yamaguchi S, ... ... Hambardzumyan D, et al. Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma. Cancer Research. PMID 29531161 DOI: 10.1158/0008-5472.Can-17-2433 |
0.637 |
|
| 2018 |
Nhat Tran A, Walker K, Harrison DG, Chen W, Mobley J, Hocevar L, Hackney JR, Sedaka RS, Pollock JS, Goldberg MS, Hambardzumyan D, Cooper SJ, Gillespie Y, Hjelmeland AB. Reactive Species Balance via GTP Cyclohydrolase I Regulates Glioblastoma Growth and Tumor Initiating Cell Maintenance. Neuro-Oncology. PMID 29409010 DOI: 10.1093/Neuonc/Noy012 |
0.477 |
|
| 2018 |
Akamandisa MP, Nie K, Wen J, Nahta R, Hambardzumyan D, Castellino RC. Abstract B05: Mechanisms of PPM1D-mediated tumorigenesis in diffuse intrinsic pontine glioma (DIPG) Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B05 |
0.487 |
|
| 2018 |
Ross J, Chen Z, Szulzewsky F, Schniederjan M, Becher O, Hambardzumyan D. PDTM-43. THE ROLE OF TUMOR ASSOCIATED MACROPHAGES IN PEDIATRIC HIGH-GRADE GLIOMA Neuro-Oncology. 20: vi213-vi213. DOI: 10.1093/Neuonc/Noy148.882 |
0.739 |
|
| 2018 |
Szulzewsky F, Arora S, Hambardzumyan D, Holland E. TMIC-53. IDENTIFICATION OF MYELOID CELL-DERIVED TRANSCRIPTS IN GLIOBLASTOMA Neuro-Oncology. 20: vi268-vi268. DOI: 10.1093/Neuonc/Noy148.1112 |
0.318 |
|
| 2018 |
Chen Z, Murukuti J, Hambardzumyan D. TMIC-31. GENETIC DRIVER-MUTATIONS DEFINE COMPOSITION AND PROPERTIES OF TUMOR-ASSOCIATED MYELOID CELLS IN GLIOBLASTOMA Neuro-Oncology. 20: vi262-vi263. DOI: 10.1093/Neuonc/Noy148.1090 |
0.602 |
|
| 2018 |
Boyd N, Ayokanmbi A, Walker K, Whetsel J, Gordillo J, Smith C, Gordon E, Herting C, Hambardzumyan D, Gillespie Y, Hackney J, Cooper S, Jiao K, Hjelmeland A. TMIC-08. CHD7 IS SUPPRESSED IN THE PERINECROTIC/ISCHEMIC MICROENVIRONMENT AND IS A NOVEL REGULATOR OF ANGIOGENESIS Neuro-Oncology. 20: vi257-vi257. DOI: 10.1093/Neuonc/Noy148.1068 |
0.506 |
|
| 2018 |
Ghosh S, Sadahiro H, Kang K, Gibson JT, Minata M, Yu H, Shi J, Chhipa R, Chen Z, Lu S, Simoni Y, Furuta T, Sabit H, Zhang S, Bastola S, ... ... Hambardzumyan D, et al. ACTR-20. A SMALL MOLECULE AXL INHIBITOR, BGB324 – FIRST-IN-HUMAN GBM SURGICAL PK TRIAL FOR RECURRENT TUMORS Neuro-Oncology. 20: vi15-vi15. DOI: 10.1093/Neuonc/Noy148.054 |
0.54 |
|
| 2018 |
Akamandisa M, Nie K, Wen J, Nahta R, Hambardzumyan D, Castellino R. DIPG-60. PPM1D MUTATION MEDIATES TUMORIGENESIS AND IS A THERAPEUTIC TARGET IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) Neuro-Oncology. 20: i61-i61. DOI: 10.1093/Neuonc/Noy059.153 |
0.308 |
|
| 2017 |
Szulzewsky F, Schwendinger N, Güneykaya D, Cimino PJ, Hambardzumyan D, Synowitz M, Holland EC, Kettenmann H. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment. Neuro-Oncology. PMID 29016864 DOI: 10.1093/Neuonc/Nox165 |
0.364 |
|
| 2017 |
Müller-Greven GM, Carlin C, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL. Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28912141 DOI: 10.1158/1078-0432.Ccr-17-0249 |
0.432 |
|
| 2017 |
Herting CJ, Chen Z, Pitter KL, Szulzewsky F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B, Hambardzumyan D. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas. Glia. PMID 28836293 DOI: 10.1002/Glia.23203 |
0.637 |
|
| 2017 |
Pan Y, Smithson LJ, Ma Y, Hambardzumyan D, Gutmann DH. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Oncotarget. PMID 28380429 DOI: 10.18632/Oncotarget.16516 |
0.52 |
|
| 2017 |
Chen Z, Feng X, Herting CJ, Alvarez Garcia V, Nie K, Pong WW, Rasmussen R, Dwivedi B, Seby S, Wolf SA, Gutmann DH, Hambardzumyan D. Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Research. PMID 28235764 DOI: 10.1158/0008-5472.Can-16-2310 |
0.668 |
|
| 2017 |
Chen Z, Hambardzumyan D. TMIC-02. GENETIC DRIVER-MUTATIONS DEFINE THE TUMORS ASSOCIATED MACROPHAGE COMPOSITION AND FUNCTION IN GLIOBLASTOMA Neuro-Oncology. 19: vi243-vi243. DOI: 10.1093/Neuonc/Nox168.992 |
0.608 |
|
| 2017 |
Oh S, Vigneswaran K, Schniederjan M, Horbinski C, Hambardzumyan D, Becher O, Kenney A, Read R. PDTM-35. THERAPEUTIC RELEVANCE OF YAP/TAZ ACTIVITY IN PEDIATRIC HIGH-GRADE GLIOMA. Neuro-Oncology. 19: vi197-vi197. DOI: 10.1093/Neuonc/Nox168.798 |
0.35 |
|
| 2017 |
Maximov V, Chen Z, Wei Y, Robinson MH, Hambardzumyan D, Kenney A. TMIC-17. THE ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN A MURINE SONIC HEDGEHOG MEDULLOBLASTOMA MODEL Neuro-Oncology. 19: vi246-vi247. DOI: 10.1093/Neuonc/Nox168.1007 |
0.637 |
|
| 2016 |
Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, ... ... Hambardzumyan D, et al. Corticosteroids compromise survival in glioblastoma. Brain : a Journal of Neurology. PMID 27020328 DOI: 10.1093/Brain/Aww046 |
0.373 |
|
| 2016 |
Chen Z, Feng X, Nie K, Pong WW, Rasmussen R, Gutmann D, Hambardzumyan D. TMIC-06. IDENTITY AND GENE PROFILE OF TUMOR-ASSOCIATED MACROPHAGES IN GLIOBLASTOMA Neuro-Oncology. 18: vi200-vi201. DOI: 10.1093/Neuonc/Now212.846 |
0.617 |
|
| 2015 |
Hambardzumyan D, Bergers G. Glioblastoma: Defining Tumor Niches. Trends in Cancer. 1: 252-265. PMID 27088132 DOI: 10.1016/J.Trecan.2015.10.009 |
0.558 |
|
| 2015 |
Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nature Neuroscience. 19: 20-7. PMID 26713745 DOI: 10.1038/Nn.4185 |
0.491 |
|
| 2015 |
Feng X, Szulzewsky F, Yerevanian A, Chen Z, Heinzmann D, Rasmussen RD, Alvarez-Garcia V, Kim Y, Wang B, Tamagno I, Zhou H, Li X, Kettenmann H, Ransohoff RM, Hambardzumyan D. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Oncotarget. 6: 15077-94. PMID 25987130 DOI: 10.18632/Oncotarget.3730 |
0.621 |
|
| 2015 |
Szulzewsky F, Pelz A, Feng X, Synowitz M, Markovic D, Langmann T, Holtman IR, Wang X, Eggen BJ, Boddeke HW, Hambardzumyan D, Wolf SA, Kettenmann H. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. Plos One. 10: e0116644. PMID 25658639 DOI: 10.1371/Journal.Pone.0116644 |
0.347 |
|
| 2015 |
Raychaudhuri B, Rayman P, Huang P, Grabowski M, Hambardzumyan D, Finke JH, Vogelbaum MA. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes. Journal of Neuro-Oncology. 122: 293-301. PMID 25579983 DOI: 10.1007/s11060-015-1720-6 |
0.374 |
|
| 2015 |
Lu K, Hambardzumyan D, Bergers G. CBIO-05UNDERSTANDING AND TACKLING PARACRINE SIGNALING CUES BETWEEN GLIOMA AND IMMUNE CELLS TO THWART GLIOMA INVASIVENESS AND ANGIOGENESIS Neuro-Oncology. 17: v55.5-v56. DOI: 10.1093/Neuonc/Nov209.05 |
0.562 |
|
| 2014 |
Leder K, Pitter K, Laplant Q, Hambardzumyan D, Ross BD, Chan TA, Holland EC, Michor F. Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell. 156: 603-16. PMID 24485463 DOI: 10.1016/J.Cell.2013.12.029 |
0.409 |
|
| 2014 |
Bae E, Smith L, Muller-Greven G, Yamada R, Joshi K, Nakano-Okuno M, Feng X, Hambardzumyan D, Nakano I, Gladson CL. AI-03 * TARGETING ANGIOGENESIS WITHOUT INCREASING THE STROMAL CELL RESPONSE OR INVASION USING ABT-898, A THROMBOSPONDIN TYPE 1 REPEAT PEPTIDE Neuro-Oncology. 16: v1-v1. DOI: 10.1093/Neuonc/Nou238.3 |
0.473 |
|
| 2014 |
Vogelbaum MA, Otvos B, Raychaudhuri B, Hambardzumyan D, Finke J, Lathia J. THE ROLE OF MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) IN TUMOR-INDUCED IMMUNOSUPPRESSION IN HUMAN AND MURINE GLIOMAS Neuro-Oncology. 16: iii44-iii44. DOI: 10.1093/NEUONC/NOU209.10 |
0.45 |
|
| 2013 |
Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, Rubin JB, Fuller GN, Piwnica-Worms D, Feng X, Hambardzumyan D, et al. F11R is a novel monocyte prognostic biomarker for malignant glioma. Plos One. 8: e77571. PMID 24147027 DOI: 10.1371/Journal.Pone.0077571 |
0.458 |
|
| 2013 |
Ding BS, James D, Iyer R, Falciatori I, Hambardzumyan D, Wang S, Butler JM, Rabbany SY, Hormigo A. Prominin 1/CD133 endothelium sustains growth of proneural glioma. Plos One. 8: e62150. PMID 23637986 DOI: 10.1371/journal.pone.0062150 |
0.324 |
|
| 2012 |
Barrett LE, Granot Z, Coker C, Iavarone A, Hambardzumyan D, Holland EC, Nam HS, Benezra R. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell. 21: 11-24. PMID 22264785 DOI: 10.1016/J.Ccr.2011.11.025 |
0.373 |
|
| 2011 |
Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F. The probable cell of origin of NF1- and PDGF-driven glioblastomas. Plos One. 6: e24454. PMID 21931722 DOI: 10.1371/Journal.Pone.0024454 |
0.331 |
|
| 2011 |
Hambardzumyan D, Parada LF, Holland EC, Charest A. Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia. 59: 1155-68. PMID 21305617 DOI: 10.1002/glia.21142 |
0.339 |
|
| 2010 |
Truman JP, García-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M, Fuks Z, Kolesnick R, Haimovitz-Friedman A. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. Plos One. 5. PMID 20941382 DOI: 10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897 |
0.331 |
|
| 2010 |
Truman JP, García-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M, Fuks Z, Kolesnick R, Haimovitz-Friedman A. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. Plos One. 5: e12310. PMID 20808818 DOI: 10.1371/Journal.Pone.0012310 |
0.332 |
|
| 2010 |
Broderick SR, Golas BJ, Pham D, Towe CW, Talbot SG, Kaufman A, Bains S, Huryn LA, Yonekawa Y, Carlson D, Hambardzumyan D, Ramanathan Y, Singh B. SCCRO promotes glioma formation and malignant progression in mice. Neoplasia (New York, N.Y.). 12: 476-84. PMID 20563250 |
0.399 |
|
| 2010 |
Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 6: 141-52. PMID 20144787 DOI: 10.1016/j.stem.2010.01.001 |
0.424 |
|
| 2010 |
Doucette TA, Kong L, Yang Y, Wei J, Wang J, Fuller GN, Heimberger AB, Rao G, Ajewung N, Kamnasaran D, Katz AM, Amankulor N, Squatrito M, Hambardzumyan D, Holland EC, et al. Tumor Models (In Vivo/In Vitro) Neuro-Oncology. 12: iv130-iv136. DOI: 10.1093/Neuonc/Noq116.S20 |
0.479 |
|
| 2009 |
Bhatia B, Northcott PA, Hambardzumyan D, Govindarajan B, Brat DJ, Arbiser JL, Holland EC, Taylor MD, Kenney AM. Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization. Cancer Research. 69: 7224-34. PMID 19738049 DOI: 10.1158/0008-5472.Can-09-1299 |
0.365 |
|
| 2008 |
Podsypanina K, Du YCN, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung Science. 321: 1841-1844. PMID 18755941 DOI: 10.1126/Science.1161621 |
0.341 |
|
| 2008 |
Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and Akt signaling Stem Cell Reviews. 4: 203-210. PMID 18595010 DOI: 10.1007/s12015-008-9021-5 |
0.328 |
|
| 2008 |
Hambardzumyan D, Becher OJ, Holland EC. Cancer stem cells and survival pathways Cell Cycle. 7: 1371-1378. PMID 18421251 |
0.443 |
|
| 2008 |
Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Research. 68: 2241-9. PMID 18381430 DOI: 10.1158/0008-5472.Can-07-6350 |
0.432 |
|
| 2008 |
Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes & Development. 22: 436-48. PMID 18281460 DOI: 10.1101/Gad.1627008 |
0.322 |
|
| 2007 |
Hambardzumyan D, Lyustikman Y, Holland EC. An update on mouse brain tumor models in cancer drug discovery. Expert Opinion On Drug Discovery. 2: 1435-51. PMID 23484596 DOI: 10.1517/17460441.2.11.1435 |
0.384 |
|
| 2007 |
McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreger AR, Woolliscroft MJ, Rehemtulla A, Ross BD, Holland EC. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma Clinical Cancer Research. 13: 2897-2904. PMID 17504989 DOI: 10.1158/1078-0432.CCR-06-3058 |
0.339 |
|
| 2007 |
Hambardzumyan D, Lyustikman Y, Holland EC. An update on mouse brain tumor models in cancer drug discovery Expert Opinion On Drug Discovery. 2: 1435-1451. DOI: 10.1517/17460441.2.11.1435 |
0.384 |
|
| 2007 |
Hambardzumyan D, Squatrito M, Holland EC. Radiation Resistance and Stem-Like Cells in Brain Tumors (DOI:10.1016/j.ccr.2006.11.008) Cancer Cell. 11: 97. DOI: 10.1016/J.Ccr.2006.12.011 |
0.435 |
|
| 2006 |
Hambardzumyan D, Squartro M, Holland EC. Radiation resistance and stem-like cells in brain tumors Cancer Cell. 10: 454-456. PMID 17157785 DOI: 10.1016/j.ccr.2006.11.008 |
0.362 |
|
| Show low-probability matches. |